Dr Kane Langdon ~ JCU Lecturer

Dr Kane Langdon is a clinical lecturer at the James Cook University College of Medicine and Dentistry, based at the clinical school in Cairns, Far North Queensland.

He graduated with Distiction from James Cook University Bachelor of Medicine/Bachelor of Surgery in 2021. During these undergraduate studies, Kane additionally completed a Bachelor of Medical Science (Hons) where he leveraged helminth secretomic research to investigate novel therapeutics in an animal model of rheumatoid arthritis. Subsequently in 2023, he completed a Master of Cancer Sciences with First Class Honours from the University of Melbourne, utilising data linkage techiques to study state wide population dynamics and outcomes for patients suffering from Acute Myeloid Leukaemia.

With the support of an Avant Early Career Researcher Program Grant, his current research is a collaboration with the University of Melbourne focused on establishing a state wide dataset of all patients suffering from haematological malignancies to further improve our understanding and treatment of these diseases.

Interests

Research

• Clinical and translational immunology
• Haematology, immuno-oncology and therapeutics
• Helminth secretomics and protein-based therapies for inflammatory disease
• Epidemiology and data linkage techniques

Experience

• 2021 to present - Clinical Lecturer, James Cook University (Australia)
• 2021 to 2023 - Master of Cancer Sciences, University of Melbourne (Australia)
• 2015 to 2021 - Bachelor of Medicine, Bachelor of Surgery, James Cook University (Australia)
• 2015 to 2020 - Student Tutor, James Cook University (Australia)
• 2018 - Bachelor of Medical Science (Hons), James Cook University (Australia)

Research Disciplines

• Immunology (3204)
• Cardiovascular medicine and haematology (3201)
• Oncology and carcinogenesis (3211)

Socio-Economic Objectives

• Clinical health (2001)

Awards

• 2022 - Best First-Time Symposium Presenter – CHHHS Research and Innovation Symposium
• 2022 - FNQ Hospital Foundation Conference Grant
• 2021 - James Cook University Dr David Graham Prize
• 2021 - Australasian Society for Clinical Immunology and Allergy Conference Poster Prize
• 2015 to 2021 - Rural Australia Medical Undergraduate Scholarship

Fellowships

• 2024 to 2025 - Avant Early Career Researcher Grant

Memberships

• 2023 - Victorian Comprehensive Cancer Centre Leadership Academy
• 2021 - Australasian Society of Clinical Immunology and Allergy – Research Associate

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU.

Journal Articles

• Langdon K, Cosentino S and Wawryk O (2024) Superiority of anthracycline-free treatment in standard-risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis. Cancer Reports, 7 (3).
• Langdon K, Buitrago G, Pickering D, Giacomin P, Loukas A and Haleagrahara N (2022) Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis. Inflammopharmacology, 30 (2). pp. 527-535
• Langdon K, Phie J, Thapa C, Biros E, Loukas A and Haleagrahara N (2019) Helminth-based therapies for rheumatoid arthritis: a systematic review and meta-analysis. International Immunopharmacology, 66. pp. 366-372
• Langdon K and Nagaraja H (2018) Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis. International Reviews of Immunology, 37 (4). pp. 206-214